C69.20 Malignant neoplasm of unspecified retina

Name of the Condition

• Malignant neoplasm of unspecified retina

Summary

This condition refers to cancerous growths originating in the retina, the light-sensitive tissue at the back of the eye responsible for visual processing. It is a rare but serious ocular malignancy that can impair vision and may spread to other parts of the body. The retina’s role in converting light into neural signals makes malignancies here particularly impactful on visual function.

Causes

The exact cause is unknown, but genetic mutations in retinal cells are suspected. Some cases may be linked to environmental factors, though specific triggers are not well-defined. Retinal malignancies often arise from uncontrolled cell growth in the retinal pigment epithelium or photoreceptor layers.

Risk Factors

• Older age.
• Prior radiation exposure to the eye or head.
• Certain genetic syndromes that elevate cancer risk (e.g., hereditary retinoblastoma).
• A history of other eye malignancies or pre-cancerous conditions.
• Light eye color may increase susceptibility.

Symptoms

• Blurred or distorted vision.
• Seeing flashes of light or floaters.
• Loss of peripheral vision (tunnel vision).
• Changes in color perception.
• Visible dark spots or shadows in the visual field.
• Pain or discomfort in advanced cases.
• Sudden vision loss.

Diagnosis

Diagnosis typically involves a thorough eye examination, including dilated funduscopy to assess the retina. Imaging tests like optical coherence tomography (OCT) or fluorescein angiography may be used to evaluate tumor extent. Biopsy of the affected tissue is performed to confirm malignancy.

Treatment Options

• Surgery to remove the tumor, if localized.
• Radiation therapy (external beam or plaque brachytherapy) to target the tumor.
• Chemotherapy (systemic or intraocular) for advanced or metastatic cases.
• Targeted therapy or immunotherapy, depending on tumor characteristics.
• Enucleation (eye removal) in severe cases to prevent spread.

Prognosis and Follow-Up

Prognosis depends on the tumor’s size, location, and extent of spread at diagnosis. Early detection improves outcomes, but advanced cases may have a poorer prognosis. Regular follow-up with eye exams and imaging is essential to monitor for recurrence or metastasis.

Complications

• Vision loss or blindness.
• Tumor spread to other parts of the eye or body (metastasis).
• Secondary glaucoma or retinal detachment.
• Pain or discomfort in advanced stages.

Lifestyle & Prevention

• Protect eyes from excessive UV light with sunglasses.
• Avoid known environmental carcinogens when possible.
• Maintain regular eye exams, especially with risk factors.
• Promptly address any vision changes or eye symptoms.

When to Seek Professional Help

Seek immediate medical attention for sudden vision loss, persistent floaters, flashes of light, or visible changes in the eye. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Use this code for malignant neoplasms of the retina when the specific site is not documented. Ensure documentation supports the diagnosis and aligns with clinical findings. Verify that the code is not used for benign or unspecified neoplasms, as specificity may affect coding accuracy.